Prevalence, molecular characterization, and prognosis of METeoverexpressing non-small cell lung cancer (NSCLC) in a real-world patient cohort

被引：1

作者：

Bar, J. ^{[1
]}

Cai, M. H. ^{[2
]}

Choi, Y. C. ^{[3
]}

Baijal, S. ^{[4
]}

Zhao, W. ^{[5
]}

Liede, A. ^{[6
]}

Raskin, L. ^{[3
]}

Vasilopoulos, A. ^{[7
]}

Li, M. ^{[8
]}

Roberts-Rapp, L. ^{[9
]}

Jiang, F. ^{[10
]}

Ratajczak, C. ^{[11
]}

Lu, S. ^{[12
]}

Ansell, P. J. ^{[13
]}

Camidge, D. R. ^{[14
]}

机构：

[1] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel

[2] AbbVie Inc Headquarters, Epidemiol, N Chicago, IL USA

[3] AbbVie Inc Headquarters, Global Epidemiol, N Chicago, IL USA

[4] Univ Hosp Birmingham NHS Fdn Trust, Dept Med Oncol, Birmingham, W Midlands, England

[5] AbbVie Inc Headquarters, Biostat, N Chicago, IL USA

[6] AbbVie Inc Headquarters, Real World Evidence Innovat & Collaborat, N Chicago, IL USA

[7] AbbVie Inc Headquarters, Precis Med & Clin Biomarker, Oncol, N Chicago, IL USA

[8] AbbVie Inc Headquarters, Compan Diagnost Strategy, N Chicago, IL USA

[9] AbbVie Inc Headquarters, Mol & Cell Biol, N Chicago, IL USA

[10] AbbVie Inc Headquarters, Cell & Mol Biol, N Chicago, IL USA

[11] AbbVie, Oncol Dev, N Chicago, IL USA

[12] Shanghai Jiao Tong Univ, Shanghai Lung Canc Ctr, Shanghai Chest Hosp, Shanghai, Peoples R China

[13] AbbVie Inc USA, Translat Med Dept, N Chicago, IL USA

[14] Univ Colorado, Med Oncol, Canc Ctr Anschutz Canc Pavil, Aurora, CO USA

来源：

关键词：

D O I：

10.1016/j.annonc.2023.09.2429

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1397P

引用

页数：2